Clarivate

NOVEMBER 17, 2021

In this episode of Conversations in Healthcare , Carolyn Hynes from AstraZeneca discusses the importance of regulatory intelligence. Moreover, being compliant with today’s regulations is not necessarily sufficient because the regulatory environment itself keeps evolving. Mike Ward: Celine, what’s your take on this topic?

Pharma 52

Pharma Healthcare Healthcare Specialization 52

Nixon Gwilt Law

APRIL 22, 2024

That said, the flurry of regulatory policymaking and legislation, congressional hearings and inquiries, and industry stakeholder organization around the development and deployment of healthcare AI portends major developments in the coming years. While industry awaits formal legislative and agency action (e.g.,

Healthcare 52

Healthcare Healthcare Training Food and Drug Administration 52

Pharmaceutical Technology

NOVEMBER 9, 2022

BioMarin’s Roctavian has a target PDUFA action date of March 31 next year. While experts interviewed by Pharmaceutical Technology found the cost-effectiveness estimates valid, the durability of gene therapies in haemophilia remains unclear, particularly in the case of Roctavian, which has faced similar queries from regulatory authorities.

Safety 111

Safety Pharmaceutical Patients Medicine 111

Healthcare Success

JANUARY 2, 2024

Artificial intelligence (AI) is when computers and other machines are used to mimic human cognition, making them capable of learning, thinking, and making decisions or taking actions. To improve search engine rankings in 2024, create a content calendar and fill it with topics that address user pain points, questions, and needs.

Healthcare 77

Healthcare Healthcare Marketing Healthcare Provider 77

Clarivate

FEBRUARY 22, 2024

In the research and development space, we help companies advance their drug discovery, preclinical proof-of-concept, and regulatory activities. Clarivate’s translational science expertise, regulatory and commercial experts and assets combine to complement client teams in generating long term value.

Consulting 64

Consulting Management Pharma Healthcare 64

PM360

JUNE 11, 2022

And what regulatory considerations must industry partners adhere to when working with patients? Live patient outreach programs (LPOPs) on the other hand are great at driving action and building a local community. Authority may not be enough to make someone popular in certain niches. Will those changes be lasting? Ilana Massi.

Patients 59

Patients Pharma Education Media 59

European Pharmaceutical Review

JULY 1, 2022

Diversity and inclusion – pharmaceutical companies may be required to comply with certain legal requirements relating to topics such as inclusion and non-discrimination. Those organisations which demonstrate good ESG policies now will be far better placed to comply with future regulatory developments and avoid penalties.

Government 92

Government Pharmaceutical Safety Consulting 92